Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-28

FDA Approved: ANASTROZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's original application for a generic anastrozole product, expanding access to this aromatase inhibitor for breast cancer treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)

Snippet

ORIG AP for ANASTROZOLE (ANASTROZOLE)